Literature DB >> 32699474

Review of Associations Between Type 2 Diabetes and Cancer.

Pranay R Bonagiri1, Jay H Shubrook1.   

Abstract

Debate is ongoing regarding the relationship between type 2 diabetes and cancer, and the pathways linking the two are incompletely understood. Some posit that the relationship hinges on a common predisposing factor such as obesity, insulin resistance, or chronic inflammation that increases the risk of cancer independently. Others speculate that diabetes acts as an independent risk factor for cancer because of other molecular pathways and interactions. Additionally, antidiabetic medications have been associated with changes in cancer risk. This review presents a summary of the latest studies and data concerning the relationships among type 2 diabetes, antidiabetic medications, cancer risk, and cancer prognosis.
© 2020 by the American Diabetes Association.

Entities:  

Year:  2020        PMID: 32699474      PMCID: PMC7364450          DOI: 10.2337/cd19-0077

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN: 0891-8929


  69 in total

Review 1.  A systematic review of the impact of weight loss on cancer incidence and mortality.

Authors:  S Birks; A Peeters; K Backholer; P O'Brien; W Brown
Journal:  Obes Rev       Date:  2012-06-04       Impact factor: 9.213

2.  Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium.

Authors:  C Bosetti; V Rosato; D Li; D Silverman; G M Petersen; P M Bracci; R E Neale; J Muscat; K Anderson; S Gallinger; S H Olson; A B Miller; H Bas Bueno-de-Mesquita; G Scelo; V Janout; I Holcatova; P Lagiou; D Serraino; E Lucenteforte; E Fabianova; P A Baghurst; W Zatonski; L Foretova; E Fontham; W R Bamlet; E A Holly; E Negri; M Hassan; A Prizment; M Cotterchio; S Cleary; R C Kurtz; P Maisonneuve; D Trichopoulos; J Polesel; E J Duell; P Boffetta; C La Vecchia; P Ghadirian
Journal:  Ann Oncol       Date:  2014-07-23       Impact factor: 32.976

3.  Diabetes mellitus and risk of breast cancer: a meta-analysis.

Authors:  Susanna C Larsson; Christos S Mantzoros; Alicja Wolk
Journal:  Int J Cancer       Date:  2007-08-15       Impact factor: 7.396

Review 4.  Obesity and cancer pathogenesis.

Authors:  Nathan A Berger
Journal:  Ann N Y Acad Sci       Date:  2014-04       Impact factor: 5.691

Review 5.  Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer.

Authors:  K M J De Bruijn; L R Arends; B E Hansen; S Leeflang; R Ruiter; C H J van Eijck
Journal:  Br J Surg       Date:  2013-10       Impact factor: 6.939

6.  Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.

Authors:  Ashish Shukla; Jean Grisouard; Volker Ehemann; Alexander Hermani; Harald Enzmann; Doris Mayer
Journal:  Endocr Relat Cancer       Date:  2009-01-19       Impact factor: 5.678

Review 7.  The role of the insulin-like growth factor-1 system in breast cancer.

Authors:  Panagiotis F Christopoulos; Pavlos Msaouel; Michael Koutsilieris
Journal:  Mol Cancer       Date:  2015-02-15       Impact factor: 27.401

8.  Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.

Authors:  Ming Zhao; Jiayi Chen; Yanyan Yuan; Zuquan Zou; Xiaolong Lai; Daud M Rahmani; Fuyan Wang; Yang Xi; Qin Huang; Shizhong Bu
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

Review 9.  Metformin as a Therapeutic Target in Endometrial Cancers.

Authors:  Teresa Y Lee; Ubaldo E Martinez-Outschoorn; Russell J Schilder; Christine H Kim; Scott D Richard; Norman G Rosenblum; Jennifer M Johnson
Journal:  Front Oncol       Date:  2018-08-28       Impact factor: 6.244

10.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal:  N Engl J Med       Date:  2016-06-13       Impact factor: 176.079

View more
  3 in total

Review 1.  Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors.

Authors:  Mariusz Dąbrowski
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

Review 2.  Gestational Diabetes, Colorectal Cancer, Bariatric Surgery, and Weight Loss among Diabetes Mellitus Patients: A Mini Review of the Interplay of Multispecies Probiotics.

Authors:  Emmanouil Benioudakis; Eleni Karlafti; Alexandra Bekiaridou; Triantafyllos Didangelos; Theodossis S Papavramidis
Journal:  Nutrients       Date:  2021-12-31       Impact factor: 5.717

3.  Association of Glycosylated Hemoglobin Level and Cancer-Related Mortality in Patients without Diabetes.

Authors:  Tae Kyung Yoo; Mi Yeon Lee; Sul A Lee; Eun Sun Cheong; Mi Hae Seo; Ki Chul Sung
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.